Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

In the phase-III GLOBE/015 studies, telbivudine demonstrated superior efficacy vs lamivudine during 2-year treatment in HBeAg-positive and HBeAg-negative chronic hepatitis B (CHB). After completion, 847 patients had an option to continue telbivudine treatment for further 2 years. A total of 596 (70%...

Saved in:

書目詳細資料
Main Authors:	Wang Y., Thongsawat S., Gane E.J., Liaw Y.-F., Jia J., Hou J., Chan H.L.Y., Papatheodoridis G., Wan M., Niu J., Bao W., Trylesinski A., Naoumov N.V.
格式:	Article
語言:	English
出版:	2014
在線閱讀:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84875229260&partnerID=40&md5=1eda83af67c7ccfd0971bbc62d162056 http://www.ncbi.nlm.nih.gov/pubmed/23490388 http://cmuir.cmu.ac.th/handle/6653943832/4045
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
由: Y. Wang, et al.
出版: (2018)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
由: Y. Wang, et al.
出版: (2018)

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
由: Gane E., et al.
出版: (2017)

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
由: Edward J. Gane, et al.
出版: (2018)

Telbivudine versus lamivudine in patients with chronic hepatitis B
由: Ching Lung Lai, et al.
出版: (2018)

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
由: Zeuzem, S., et al.
出版: (2016)

Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial
由: Chan, H.L.Y., et al.
出版: (2016)

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy
由: Marcellin Patrick, et al.
出版: (2016)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: Results from the 2-year roadmap strategy
由: Teerha Piratvisuth, et al.
出版: (2018)

Telbivudine: A hepatitis B-specific antiviral
由: Lim, S.G.
出版: (2011)

Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: Pharmacodynamic implications
由: Zhou, X.-J., et al.
出版: (2016)

Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
由: Soon, D.K.W., et al.
出版: (2014)

Ragaman Genetik Gen Polimerase Virus Hepatitis B Pada Pasien Hepatitis B Kronik dengan Pengobatan Telbivudine
由: Mastutik, Gondo, et al.
出版: (2015)

Evaluation of one-year lamivudine and telbivudine therapy on chronic hepatitis b patients: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital
由: Ummi Maimunah, et al.
出版: (2019)

Evaluation of one year lamivudine and telbivudine therapy on chronic hepatitis b patient: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital
由: Ummi Maimunah, et al.
出版: (2019)

Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B
由: Keeffe, E.B., et al.
出版: (2016)

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
由: Yun Fan Liaw, et al.
出版: (2018)

Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
由: Ahn, S.H., et al.
出版: (2011)

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
由: Marcellin, P., et al.
出版: (2016)

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
由: Colvin,R.A., et al.
出版: (2015)

Analisis Gen P Virus Hepatitis B (VHB) pada Serum Penderita Hepatitis B Kronik yang mendapat pengobatan Telbivudine dikaitkan dengan jumlah muatan virus sebelum pengobatan
由: Mastutik, Gondo, et al.
出版: (2010)

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
由: Hadziyannis, S.J., et al.
出版: (2014)

Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B
由: You, H, et al.
出版: (2020)

Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6
由: Ong The Due, et al.
出版: (2020)

EVALUASI PEMBERIAN TERAPI LAMIVUDIN DAN TELBIVUDIN PADA PASIEN HEPATITIS B KRONIS DI RSUD DR. SOETOMO SURABAYA PADA PERIODE TERAPI 2014 – 2015
由: Erik Geraldus Edison, NIM011511133143
出版: (2018)

The economics of treating chronic hepatitis B in Asia
由: Dan, Y.Y., et al.
出版: (2011)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: Lau G.K.K., et al.
出版: (2014)

Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
由: Guan, R., et al.
出版: (2014)

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
由: Kao J., et al.
出版: (2017)

Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program
由: Peto, Thomas J., et al.
出版: (2014)

Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program
由: Thomas J. Peto, et al.
出版: (2018)

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B
由: Tan, A.T., et al.
出版: (2011)

Applicability of cost-effectiveness analysis to management of chronic hepatitis B
由: Dan, Y.Y., et al.
出版: (2011)

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
由: Chang, T.-T., et al.
出版: (2016)

Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy
由: Kumthip K., et al.
出版: (2014)

Cost of Illness of Chronic Hepatitis B Infection in Vietnam
由: Hong Anh T Tu, et al.
出版: (2018)

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
由: Marcellin, P., et al.
出版: (2014)

Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy
由: Kattareeya Kumthip, et al.
出版: (2018)

Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy
由: Kattareeya Kumthip, et al.
出版: (2018)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: George K.K. Lau, et al.
出版: (2018)